Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant's Shield™ Blood-based Screening Test in the United States

Group 1 - Guardant Health, Inc. and Quest Diagnostics have announced a strategic collaboration to provide Guardant's Shield blood-based screening test to physicians and patients in the United States [1] - Shield is the first and only blood test to receive full FDA approval as a primary screening option for colorectal cancer [1]